BIOHELLENIKA OFFERS NEW PRODUCTS BASED ON STEM CELLS FOR THE TREATMENT OF CHRONIC EYE DISEASE
BIOHELLENIKA OFFERS NEW PRODUCTS BASED ON STEM CELLS FOR THE TREATMENT OF CHRONIC EYE DISEASE
The Eye Institute, OPHTHALMICA, based in Thessaloniki Greece, a modern center of integrated treatment of eye diseases collaborates with Biohellenika in the treatment of ocular surface diseases, injuries and chemical burns.
Biohellenika a modern accredited biotechnology company, with laboratories in Thessaloniki and Athens Greece, that meet international standards, offers to patients through the Eye Institute OPHTHALMICA a range of products based on stem cells and blood products for the treatment of chronic diseases of the cornea and anterior segment diseases, in general.
Stem cells are now the cutting edge of medicine and biotechnology and providing high services in Ophthalmology we improve the quality of life and protect people from blindness.